ArticleJournal of exposure science & environmental epidemiology2026
Portable Cd-109/CZT KXRF system for in vivo bone lead measurement: a field-deployable method for assessing cumulative lead exposure.
Article in Journal of exposure science & environmental epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBone lead (Pb) serves as a strong indicator of cumulative Pb exposure and reflects long-term body burden. K-shell X-ray fluorescence (KXRF) remains the accepted method for in vivo bone Pb assessment, yet traditional systems rely on high-purity germanium detectors that require cryogenic cooling. These physical constraints limit access to cumulative exposure measurement in many populations.
objectiveThe study examined a portable KXRF system with a room-temperature detector to determine whether its performance matches the detection capability of laboratory-based HPGe KXRF. The study assessed detection limits and evaluated agreement with reference bone Pb measurements.
methodsPb-doped bone phantoms with concentrations from 0 to 100 ppm established calibration relations for the portable system. Thirty measurements of a 0-ppm phantom established a baseline detection limit that was then normalized to reflect performance under conditions that match standard HPGe acquisition parameters. Cadaver tibias with known Pb content were evaluated, and results were compared with values from an established benchtop XRF method.
resultsThe portable system produced linear calibration results across the full phantom range (R² = 0.987). Cadaver tibia results aligned with the benchtop XRF values (R² = 0.777). The normalized detection limit reached the 2-3 ppm range, which mirrors the sensitivity of HPGe systems despite the absence of cryogenic cooling. SIGNIFICANCE: The findings show that portable KXRF can support assessment of cumulative Pb exposure in settings without access to laboratory-based HPGe instruments. The system expands opportunities for bone Pb evaluation in clinical environments and field studies and strengthens exposure assessment in populations with limited access to specialized facilities. IMPACT: This study shows that bone lead can be measured with a portable KXRF system that matches the sensitivity of laboratory HPGe instruments. The work addresses a gap in exposure science because cumulative lead burden remains difficult to quantify outside specialized facilities. By removing cryogenic cooling and fixed laboratory requirements, this system supports real-world exposure assessment in community, clinical, and field settings. The results create a practical path toward broader surveillance of long-term lead exposure, especially in populations and environments where traditional KXRF instruments are not feasible.
Indexed as
Identifiers
42426431What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.